SEELOS THERAPEUTICS INC (SEEL)

US81577F2083 - Common Stock

0.2424  -0.03 (-11.89%)

Premarket: 0.2469 +0 (+1.86%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
2.20M0.000.000.00380.00K
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
42.70M70.92M61.67M18.76M30.12M
Research and Development
30.12M58.62M46.65M10.98M22.56M
Selling, General, and Administrative Expenses
12.59M12.30M15.02M7.78M7.56M
Operating Income
-40.50M-70.92M-61.67M-18.76M-29.75M
Interest Income/Expense
123.00K110.00K-1.85M-120.00K10.00K
Other Income/Expense
11.64M-2.73M-290.00K-220.00K-21.52M
Non Recurring Items
-9.15M0.00-2.24MN/AN/A
Income Before Taxes
-37.88M-73.53M-66.05M-19.10M-51.26M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-37.88M-73.53M-66.05M-19.10M-51.26M
EBITDA
N/AN/AN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-7.73-0.69-0.73-0.43-2.52
Non GAAP EPS
-14.59-10.83-0.75-0.44-1.88
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
-1719.56%N/AN/AN/A-13489.47%
Operating Profit Margin
-1838.36%N/AN/AN/A-7828.95%

All data in USD

Charts